Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
9.37
+0.01 (0.11%)
At close: Nov 9, 2026, 4:00 PM EST
9.37
0.00 (0.00%)
After-hours: Nov 9, 2026, 8:00 PM EST
Pelthos Therapeutics Stock Forecast
PTHS's stock price has decreased by -73.4% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 7 analysts polled by S&P Global, Pelthos Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $49.57. The average 1-year stock price forecast is 429.03% higher than the current stock price, while the lowest is $30 (+220.17%) and the highest is $64 (+583.03%).
Price Target: $49.57 (+429.03%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +540.34% | Nov 5, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $55 | Buy | Maintains | $55 | +486.98% | Nov 4, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Maintains $45 → $30 | Buy | Maintains | $45 → $30 | +220.17% | Oct 26, 2026 |
| Lake Street | Lake Street | Buy Maintains $50 → $40 | Buy | Maintains | $50 → $40 | +326.89% | Oct 12, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $48 | Buy | Reiterates | $48 | +412.27% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
62.36M
from 16.80M
Increased by 271.30%
Revenue Next Year
108.40M
from 62.36M
Increased by 73.82%
EPS This Year
-18.02
from -13.29
EPS Next Year
-5.37
from -18.02
EPS and Forward PE are based on non-GAAP adjusted numbers.